share_log

Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program

Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program

Clearmind Medicine獲得來自美國專利和商標局的新專利批准,標誌着其基於MEAI的暴食行爲調節劑計劃取得了重大進展。
Benzinga ·  08/21 16:12

Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program

Clearmind Medicine 獲得美國專利和商標局的新專利批准,標誌着其基於 MEAI 的專有狂歡行爲監管計劃取得了重大進展

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論